Das K., Harria C., Smyth Dpl, Cross JH: Unusual side effects of lamotrigine therapy. J Child Neurol2003;18:479—480.
2.
Leach MJ, Lees G., Riddall DR: Lamotrigine: Mechanisms of action, in Levy RH, Mattson RH, Meldrum BS (eds): Antidepileptic Drugs, 4th ed. New York, Raven Press, 1995, 861—869.
3.
Shinotoh H., Vingerhoets Fjg, Lee CS: Lamotrigine trial in idiopathic parkinsonism: A double-blind, placebo-controlled, crossover study. Neurology1997;48:1282—1285.
4.
Zaatreh M., Tennison M., Cruz O., Beach RL: Anticonvulsants-induced chorea: A role for pharmacodynamic drug interaction?Seizure2001;10:596—599.
5.
Uberall MA, Wenzel D.: Effectiveness of lamotrigine in children with paroxysmal kinesigenic choreoathetosis . Dev Med Child Neurol2000 ;42:699—700.
6.
Pereira AC, Loo WJ, Bamford M., Wroe SJ: Use of lamotrigine to treat paroxysmal kinesigenic choreoathetosis . J Neurol Neurosurg Psychiatry2000;68:796—797.
7.
Starr MS, Starr BS, Kaur S.: Stimulation of basal and L-DOPA-induced motor activity by glutamate antagonists in animal models of Parkinson's disease. Neurosci Biobehav Rev1997;21:437—446.